DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Mega JL, Braunwald E, Mohanavelu S. , et al; ATLAS ACS-TIMI 46 study group.
Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial.
Lancet 2009;
374 (9683): 29-38
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.